An MRA is recommended for patients with persisting symptoms (NYHA Class II–IV) and an EF ≤35% despite therapy with an ACE inhibitor (or ARB) and a beta-blocker (Class I; Level A recommendation) Ensure ...
A drug costing less than 2 euros per dose could reduce the long term consequences of a heart attack, benefitting millions of patients. Metoprolol, a member of the beta-blocker class of drugs that has ...
These blood-pressure-lowering drugs can calm the rapid heartbeat, shaky voice and trembling hands that can wreck a ...
A drug costing less than 2 euros per dose could reduce the long term consequences of a heart attack, benefitting millions of patients. Metoprolol, a member of the beta-blocker class of drugs that has ...
A large new study conducted in Spain and Italy found that beta blockers, drugs often used to slow the heart rate and lower blood pressure, did not provide clear benefits for heart attack patients ...
Two new studies point in opposite directions. A large new study conducted in Spain and Italy found that beta blockers, drugs often used to slow the heart rate and lower blood pressure, did not provide ...
Depression was not more common in patients who used beta-blockers. The rate of discontinuing medications due to depression was the same for people taking beta-blockers compared to people taking other ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback